Ampullary Neuroendocrine Tumor: A Rare Cause of Recurrent Abdominal Pain


Ampullary Neuroendocrine tumor (ANET) is a rare GI malignancy, representing less than 1% of GI neuroendocrine tumors and less than 2% of ampullary tumors. Traditional treatment is often a pancreaticoduodenectomy; however, local and endoscopic resections have been successful. We report a rare case of ANET in a 21-year-old Burmese man who presented with a 6-year history of non-specific intermittent abdominal pain who was successfully managed through transduodenal ampullectomy. At 24 months postoperatively he remains disease and symptom free. ANET is a rare cause of recurrent abdominal pain, and local excision of small ANETs can be an alternative, less morbid treatment for young patients. We follow the case with a brief review of the literature.

Share and Cite:

Ofosu, A. , Taccone, M. , Potakamuri, L. and Jagannath, S. (2014) Ampullary Neuroendocrine Tumor: A Rare Cause of Recurrent Abdominal Pain. Case Reports in Clinical Medicine, 3, 139-144. doi: 10.4236/crcm.2014.33034.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Ricci, J.L. (1993) Carcinoid of the Ampulla of Vater: Local Resection or Pancreaticoduodenectomy. Cancer, 71, 686-690.<686::AID-CNCR2820710306>3.0.CO;2-Z
[2] Ramage, J.K., Davies, A.H.G., Ardill, J., Bax, N., Caplin, M., Grossman, A., et al. (2005) Guidelines for the Management of Gastroenteropancreatic Neuroendocrine (Including Carcinoid) Tumours. Gut, 54, iv1-iv16.
[3] Albores-Saavedra, J., Hart, A., Chablé-Montero, F. and Henson, D.E. (2010) Carcinoids and High-Grade Neuroendocrine Carcinomas of the Ampulla of Vater: A Comparative Analysis of 139 Cases from the Surveillance, Epidemiology, and End-Results Program—A Population Based Study. Archives of Pathology & Laboratory Medicine, 134, 1692-1696.
[4] Gilani, N. and Ramirez, F.C. (2007) Endoscopic Resection of an Ampullary Carcinoid Presenting with Upper Gastrointestinal Bleeding: A Case Report and Review of the Literature. World Journal of Gastroenterology, 13, 1268-1270.
[5] Senda, E., Fujimoto, K., Ohnishi, K., Higashida, A., Ashida, C., Okutani, T., et al. (2009) Minute Ampullary Carcinoid Tumor with Lymph Node Metastases: A Case Report and Review of Literature. World Journal of Surgical Oncology, 7, 9.
[6] Jaoude, W.A., Lau, C., Sugiyama, G. and Duncan, A. (2010) Management of Ampullary Carcinoid Tumors with Pancreaticoduodenectomy. Journal of Surgical Case Reports, 8, 4.
[7] Klimstra, D., Modlin, I.R., Coppola, D., Lloyd, R.V. and Suster, S. (2010) The Pathologic Classification of Neuroendocrine Tumors: A Review of Nomenclature, Grading and Staging Systems. Pancreas, 39, 707-712.
[8] Bosman, F., Carneiro, F., Hruban, R. and Theise, N. (2010) WHO Classification of Tumors of the Digestive System. IARC Press, Lyon.
[9] Carter, J.T., Grenert, J.P., Rubenstein, L., Stewart, L. and Way, L.W. (2009) Neuroendocine Tumors of the Ampulla of Vater: Biological Behavior and Surgical Management. Archives of Surgery, 144, 527-531.
[10] Singhal, D., Vasdev, N., Soin, A., Gupta, S. and Nundy, S. (2006) Distinguishing between Periampullary Carcinoid and Carcinomas—Is This Possible Preoperatively? Indian Journal of Gastroenterology, 25, 206-207.
[11] Hatzitheoklitos, E., Buchler, M.W., Friess, H., Poch, B., Ebert, M., Mohr, W., et al. (1994) Carcinoid of the Ampulla of Vater. Clinical Characteristics and Morphologic Features. Cancer, 73, 1580-1588.<1580::AID-CNCR2820730608>3.0.CO;2-0
[12] Norton, J.A.,Kivlen, M., Li, M., Schneider, D., Chuter, T. and Jensen, R.T. (2003) Morbidity and Mortality of Aggressive Resection in Patients with Advanced Neuroendocrine Tumors. Archives of Surgery, 138, 859-866.
[13] Poultides, G.A. and Frederick, W.A. (2006) Carcinoid of the Ampulla of Vater: Morphologic Features and Clinical Implications. World Journal of Gastroenterology, 12, 7058-7060.
[14] Hwang, S., Lee, S.G., Lee, Y.J., Han, D.J., Kim, S.C., Kwon, S.H., et al. (2008) Radical Surgical Resection for Carcinoid Tumors of the Ampulla. Journal of Gastrointestinal Surgery, 12, 713-717.
[15] Oberg, K. (2004) Management of Neuroendocrine Tumours. Annals of Oncology, 15, iv293-iv298.
[16] Oberg, K. and Eriksson, B. (2005) Nuclear Medicine in the Detection, Staging and Treatment of Gastrointestinal Carcinoid Tumours. Best Practice & Research. Clinical Endocrinology & Metabolism, 19, 265-276.
[17] Hochwald, S.N., Zee, S., Conlon, K.C., Colleoni, R., Louie, O., Brennan, M.F., et al. (2002) Prognostic Factors in Pancreatic Endocrine Neoplasms: An Analysis of 136 Cases with a Proposal for Low-Grade and Intermediate-Grade Groups. Journal of Clinical Oncology, 20, 2633-2642.
[18] Pyun, D.K., Moon, G., Han, J., Kim, M.H., Lee, S.S., Seo, D.W., et al. (2004) A Carcinoid Tumor of the Ampulla of Vater Treated by Endoscopic Snare Papillectomy. Korean Journal of Internal Medicine, 19, 257-260.
[19] Sakka, N., Smith, R.A., Whelan, P., Ghaneh, P., Sutton, R., Raraty, M., et al. (2009) A Preoperative Score for Resected Pancreatic and Periampullary Neuroendocrine Tumors. Pancreatology, 9, 670-676.
[20] Jarufe, N.P., Coldham, C., Orug, T., Mayer, A.D., Mirza, D.F., Buckels, J.A., et al. (2005) Neuroendocrine Tumors of the Pancreas: Predictors of Survival after Surgical Treatment. Digestive Surgery, 22, 157-162.

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.